The PennZone

  • Home
  • Business
  • Health
  • Non-profit
  • Education
  • Technology
  • Entertainment
  • Financial
  • Marketing

STS Capital Partners Celebrates Its 20th Anniversary 
The PennZone/10223283

Trending...
  • xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
  • Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
  • "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
STS Capital Partners
Over the course of 20 years, STS Capital Partners established itself as a global M&A firm that has helped thousands of entrepreneurial business owners on their journey toward an Extraordinary Exit

TORONTO & LONDON & LOS ANGELES - PennZone -- STS Capital Partners is excited to announce its 20th anniversary. For more than two decades, STS has remained steadfast in its commitment to make Extraordinary Exits possible and to unlock legacy potential for entrepreneurial, private, and family business owners.

Since its founding in 2003, STS has grown into a trusted international firm with more than 25 managing directors and partners, 150 team members, and an extended network of experts and advisors that includes over 4,100 professionals worldwide.

Additionally, STS has plans to commemorate its 20-year anniversary milestone throughout 2023, which includes a fundraising event for charity. Giving back aligns with the firm's ongoing goal of creating billions of dollars in new philanthropic and impact capital through M&A.

More on The PennZone
  • Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
  • Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
  • Author Chandra Donelson Visits the Children's Museum of Pittsburgh
  • Chandra Donelson Headlines the Hike2 Innovation Summit 2025
  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3

STS Capital Partners CEO Sean Friday also sees the anniversary as an opportunity to reflect on the significant progress the organization has made.

"20 years ago, our founder Rob Follows had a vision to grow STS into a global team of expert guides who help private business owners everywhere achieve Extraordinary Exits," said Friday.

"We are proud to help realize that vision in the current scale of our organization. We look forward to continuing the growth of our firm and network so we can help even more clients on the strategic journey of selling their business and delivering extraordinary value, both for financial net worth and legacy potential."

About STS Capital Partners

STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.

More on The PennZone
  • Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
  • Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
  • ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
  • Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
  • Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa

Visit www.stscapital.com.

Contact
Jena Hodgson
***@stscapital.com


Source: STS Capital Partners
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • ABM for Good™ Launches First Project with Build Change
  • Braces for Teenagers in Allentown Offered by Exeter Smiles
  • Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
  • JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
  • Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
  • Jay Tapp was named Managing Director in British Columbia
  • Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
  • GormanSquared Announces Provisional Patent
  • Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
  • 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
  • NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
  • Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
  • Chewy Chums™ Launches NeverBite™ on Kickstarter
  • DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
  • Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
  • Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
  • Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
  • Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
  • $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma

Popular on PennZone

  • Gas Wolf® Officially Becomes a Registered Trademark - 1275
  • Village Vapes and Cooking 4 Autism Announce Inaugural Partnership at MEGA 420 EVENT - 139
  • Jed the Fish, The Rapscallion of Los Angeles KROQ's Airwaves and Provocateur, Has Signed Off at 69 - 117
  • The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy
  • Goosechase Rolls Out Unlockable Missions, Its Most Anticipated Feature Yet
  • Portland Hosts Mensa's 2025 Mind Games®
  • PebblePad Welcomes Justin Reilly as New CEO to Drive Innovation and Growth
  • HR Tech Awards Program Celebrates 6th Year: Showcases Top Hiring, Talent, and HR Technologies
  • Museum Hack Presents Hacked Gala: A Rebellious Night of Art, Fashion, and Change at the Met
  • Damian Redd's "Caught in a Fantasy" Surpasses 100,000 Views on VEVO/YouTube Following Album Reissue

Similar on PennZone

  • Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution
  • QVC Honors Elton John with Inaugural Icon Award
  • Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
  • ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
  • Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
  • Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
  • Cybersecurity is Protecting Your Personal Information and Your Portfolio
  • The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
  • $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us